| Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs F Fabbri, S Carloni, W Zoli, P Ulivi, G Gallerani, P Fici, E Chiadini, ... Cancer letters 335 (1), 225-231, 2013 | 250 | 2013 |
| Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations G Barriere, P Fici, G Gallerani, F Fabbri, W Zoli, M Rigaud Annals of translational medicine 2 (11), 2014 | 180 | 2014 |
| Epithelial mesenchymal transition: a double-edged sword G Barriere, P Fici, G Gallerani, F Fabbri, M Rigaud Clinical and translational medicine 4, 1-6, 2015 | 155 | 2015 |
| Circulating tumor cells in early breast cancer: A connection with vascular invasion R Maltoni, P Fici, D Amadori, G Gallerani, C Cocchi, M Zoli, A Rocca, ... Cancer letters 367 (1), 43-48, 2015 | 44 | 2015 |
| CTCs in early breast cancer: A path worth taking R Maltoni, G Gallerani, P Fici, A Rocca, F Fabbri Cancer letters 376 (2), 205-210, 2016 | 36 | 2016 |
| Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer P Fici, G Gallerani, AP Morel, L Mercatali, T Ibrahim, E Scarpi, D Amadori, ... Oncotarget 8 (2), 2423, 2017 | 34 | 2017 |
| Single-cell NGS-based analysis of copy number alterations reveals new insights in circulating tumor cells persistence in early-stage breast cancer T Rossi, G Gallerani, D Angeli, C Cocchi, E Bandini, P Fici, M Gaudio, ... Cancers 12 (9), 2490, 2020 | 27 | 2020 |
| Adipocytes and microRNAs crosstalk: a key tile in the mosaic of breast cancer microenvironment E Bandini, T Rossi, G Gallerani, F Fabbri Cancers 11 (10), 1451, 2019 | 21 | 2019 |
| Circulating tumor cells in the adenocarcinoma of the esophagus G Gallerani, F Fabbri International Journal of Molecular Sciences 17 (8), 1266, 2016 | 18 | 2016 |
| Stemness underpinning all steps of human colorectal cancer defines the core of effective therapeutic strategies A Visioli, F Giani, N Trivieri, R Pracella, E Miccinilli, MG Cariglia, ... EBioMedicine 44, 346-360, 2019 | 14 | 2019 |
| Characterization of tumor cells using a medical wire for capturing circulating tumor cells: a 3D approach based on immunofluorescence and DNA FISH G Gallerani, C Cocchi, M Bocchini, F Piccinini, F Fabbri JoVE (Journal of Visualized Experiments), e56936, 2017 | 10 | 2017 |
| ARID1A in cancer: Friend or foe? B Fontana, G Gallerani, I Salamon, I Pace, R Roncarati, M Ferracin Frontiers in Oncology 13, 1136248, 2023 | 8 | 2023 |
| Circulating tumor cells as a tool to untangle the breast cancer heterogeneity issue T Rossi, G Gallerani, G Martinelli, R Maltoni, F Fabbri Biomedicines 9 (9), 1242, 2021 | 8 | 2021 |
| Circulating tumor cells: back to the future G Gallerani, P Fici, F Fabbri Frontiers in Oncology 6, 275, 2017 | 8 | 2017 |
| The GILUPI CellCollector as an in vivo tool for circulating tumor cell enumeration and molecular characterization in lung cancer patients. K Luecke, L Gasiorowski, S Herold, N Brychta, G Gallerani, T Krahn, ... Journal of Clinical Oncology 33 (15_suppl), e22035-e22035, 2015 | 7 | 2015 |
| Epithelial mesenchymal transition: a double-edged sword. Clin Transl Med. 2015; 4: 14 G Barriere, P Fici, G Gallerani, F Fabbri, M Rigaud PUBMED, 0 | 7 | |
| Dissecting molecular heterogeneity of circulating tumor cells (CTCs) from metastatic breast cancer patients through copy number aberration (CNA) and single nucleotide variant … T Rossi, D Angeli, M Tebaldi, P Fici, E Rossi, A Rocca, M Palleschi, ... Cancers 14 (16), 3925, 2022 | 6 | 2022 |
| Crowdfunding for cancer research: the TRACe campaign as an example G Gallerani, P Fici, A Coatti, P Mariotti, F Passeri, L Battistelli The Lancet Oncology 20 (5), 622-624, 2019 | 6 | 2019 |
| Early detection and investigation of extracellular vesicles biomarkers in breast cancer E Bandini, T Rossi, E Scarpi, G Gallerani, I Vannini, S Salvi, I Azzali, ... Frontiers in Molecular Biosciences 8, 732900, 2021 | 5 | 2021 |
| DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy S Carloni, G Gallerani, A Tesei, E Scarpi, GM Verdecchia, S Virzì, F Fabbri, ... OncoTargets and therapy, 4657-4664, 2017 | 5 | 2017 |
Tania RossiVerified email at irst.emr.it
Tania RossiVerified email at irst.emr.it